Related Experiment Video
Updated: Mar 19, 2026

Density Gradient Ultracentrifugation for Investigating Endocytic Recycling in Mammalian Cells
Published on: June 30, 2021
Ral-Arf6 crosstalk regulates Ral dependent exocyst trafficking and anchorage independent growth signalling
Archana Pawar1, Jeremy A Meier2, Anwesha Dasgupta1
1Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pashan, Pune 411 008, Maharashtra, India.
Abstract:
Integrin dependent regulation of growth factor signalling confers anchorage dependence that is deregulated in cancers. Downstream of integrins and oncogenic Ras the small GTPase Ral is a vital mediator of adhesion dependent trafficking and signalling. This study identifies a novel regulatory crosstalk between Ral and Arf6 that controls Ral function in cells. In re-adherent mouse fibroblasts (MEFs) integrin dependent activation of RalA drives Arf6 activation. Independent of adhesion constitutively active RalA and RalB could both however activate Arf6. This is further conserved in oncogenic H-Ras containing bladder cancer T24 cells, which express anchorage independent active Ral that supports Arf6 activation. Arf6 mediates active Ral-exocyst dependent delivery of raft microdomains to the plasma membrane that supports anchorage independent growth signalling. Accordingly in T24 cells the RalB-Arf6 crosstalk is seen to preferentially regulate anchorage independent Erk signalling. Active Ral we further find uses a Ral-RalBP1-ARNO-Arf6 pathway to mediate Arf6 activation. This study hence identifies Arf6, through this regulatory crosstalk, to be a key downstream mediator of Ral isoform function along adhesion dependent pathways in normal and cancer cells.
Insights
This study reveals a new link between Ral and Arf6 GTPases, crucial for cell adhesion and cancer growth. This Ral-Arf6 interaction controls cell signaling pathways essential for anchorage-independent growth in cancer.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Integrin-mediated signaling regulates anchorage dependence, a process often disrupted in cancer.
- The small GTPase Ral is a key mediator of adhesion-dependent trafficking and signaling downstream of integrins and oncogenic Ras.
- Understanding Ral's regulatory mechanisms is vital for cancer therapy development.
Purpose of the Study:
- To identify novel regulatory crosstalk involving the small GTPase Ral.
- To elucidate the role of this crosstalk in adhesion-dependent and anchorage-independent cell signaling.
- To determine the significance of this pathway in both normal and cancer cells.
Main Methods:
- Utilized mouse fibroblasts (MEFs) and human bladder cancer T24 cells.
- Investigated integrin-dependent and constitutive activation of Ral isoforms (RalA, RalB).
- Analyzed the activation of Arf6 and its downstream effects on cell signaling pathways, including Erk signaling.
Main Results:
- Identified a novel regulatory crosstalk between Ral and Arf6, where integrin-dependent RalA activation drives Arf6 activation in MEFs.
- Demonstrated that constitutively active RalA and RalB can activate Arf6 independently of cell adhesion.
- Showed that the Ral-Arf6 pathway mediates the delivery of raft microdomains to the plasma membrane, supporting anchorage-independent growth and Erk signaling in T24 cancer cells.
Conclusions:
- Arf6 acts as a key downstream mediator of Ral isoform function in adhesion-dependent pathways.
- The identified Ral-Arf6 crosstalk is crucial for anchorage-independent growth signaling in cancer.
- This pathway represents a potential therapeutic target for cancers with deregulated adhesion signaling.
More Related Videos
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Intracellular Signaling Affects Focal Adhesions
Some...
Rab Cascades
Cytoskeletal Coordination in Cell Migration
Mechanism of Lamellipodia Formation
The Ras Gene
Ras is a...

